When OpenAI announced GPT-5.2-Codex, the company confirmed that its agentic tool can stay on track for long tasks, keep a ...
Nucleome Therapeutics ('Nucleome' or 'the Company'), a company tackling the molecular causes of inflammatory diseases through a breakthrough approach to 3D human genetics, provides an R&D update ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback